Samalin Investment Counsel LLC Raises Stock Position in agilon health, inc. (NYSE:AGL)

Samalin Investment Counsel LLC raised its holdings in shares of agilon health, inc. (NYSE:AGL) by 378.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 60,545 shares of the company’s stock after purchasing an additional 47,885 shares during the period. Samalin Investment Counsel LLC’s holdings in agilon health were worth $115,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. KLP Kapitalforvaltning AS purchased a new stake in shares of agilon health during the fourth quarter worth about $111,000. Intech Investment Management LLC grew its position in agilon health by 99.6% during the 4th quarter. Intech Investment Management LLC now owns 115,693 shares of the company’s stock worth $220,000 after purchasing an additional 57,726 shares during the last quarter. Signaturefd LLC increased its stake in agilon health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after purchasing an additional 8,467 shares in the last quarter. Cibc World Markets Corp purchased a new position in shares of agilon health in the fourth quarter worth $55,000. Finally, Wealthfront Advisers LLC acquired a new stake in shares of agilon health during the fourth quarter worth $51,000.

Analyst Ratings Changes

A number of equities research analysts recently commented on AGL shares. Macquarie began coverage on agilon health in a research report on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price on the stock. Royal Bank of Canada increased their price objective on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and boosted their target price for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Stifel Nicolaus increased their price target on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research report on Wednesday, February 26th. Finally, Sanford C. Bernstein upped their target price on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research note on Wednesday, January 15th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $3.95.

agilon health Trading Up 10.1 %

Shares of AGL stock opened at $4.51 on Monday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $7.73. The company’s 50-day moving average price is $3.51 and its 200-day moving average price is $2.94. The stock has a market cap of $1.86 billion, a price-to-earnings ratio of -4.80 and a beta of 0.67.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.